Skip to main content

Table 1 Demographic and clinical characteristics of patients and controls included in this study

From: Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β

 

CSF donors database

Serum donors database

 

AD (n = 41)

Control (n = 23)

AD (n = 36)

Control (n = 24)

Age, y median (IQR)

68 (66–72)

69 (63–73)

68 (66–70)

70 (64–72)

Sex, f/m (% f/m)

29/12 (70.7)

13/10 (56.5)

25/11 (69.4)

12/12 (50.0)

MMSE, median (IQR)

21.5 (17.0–24.0)*

29.0 (n = 12) (28.0–30.0)

21.0 (17.0–23.5)*

29.0 (n = 14) (28.0–30.0)

CSF Aβ42 (pg/ml), median (IQR)

472.0 (367.0–569.0)*

1014.0 (n = 14) (875.8–1191.8)

476.0 (373.8–577.3)*

1014.0 (n = 14) (875.8–1191.8)

CSF T-tau (pg/ml), median (IQR)

616.0 (371.0–1009.0)*

228.0 (n = 14) (204.8–279.8)

659.0 (412.8–1129.0)*

228.0 (n = 14) (204.8–279.8)

  1. Data are presented as median values and interquartile ranges (IQR). 31 AD patients as well as 21 controls donated both CSF and serum. p-values were calculated using the Mann-Whitney test, AD vs. control *p < 0.0001